Cargando…
Frontiers in Pharmacology: Review Manuscript Targeting of the Neutrophil as an Adjunctive Strategy in Non-Small Cell Lung Cancer
Lung cancer remains the leading cause of cancer mortality in the United States, with non-small cell lung cancer (NSCLC) accounting for around 85% of cases. Of particular concern is the poor responsiveness of this malignancy to therapy, resulting in a very low 5-year survival rate (17.4%) and a promi...
Autores principales: | Anderson, Ronald, Blidner, Ada Gabriela, Rapoport, Bernardo Leon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218630/ https://www.ncbi.nlm.nih.gov/pubmed/34168563 http://dx.doi.org/10.3389/fphar.2021.676399 |
Ejemplares similares
-
Pulmonary Toxicities Associated With the Use of Immune Checkpoint Inhibitors: An Update From the Immuno-Oncology Subgroup of the Neutropenia, Infection & Myelosuppression Study Group of the Multinational Association for Supportive Care in Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2021) -
Antisense oligonucleotides: a novel Frontier in pharmacological strategy
por: Collotta, D., et al.
Publicado: (2023) -
Recalcitrant Issues and New Frontiers in Nano-Pharmacology
por: Bhardwaj, Vinay, et al.
Publicado: (2019) -
Editorial: Emerging talents in Frontiers in pharmacology: Gastrointestinal and hepatic pharmacology 2022
por: Grasa, Laura, et al.
Publicado: (2022) -
Editorial: Emerging researchers in frontiers in pharmacology: obstetric and pediatric pharmacology 2022
por: Yang, Qiwei, et al.
Publicado: (2023)